Incannex Healthcare (IXHL) Interest Expenses (2023 - 2026)
Incannex Healthcare (IXHL) posted Interest Expenses of $123000.0 for Q1 2026, down 30.11% sequentially from $176000.0 in Q4 2025, and down 61.32% YoY from $318000.0 in Q1 2025.
Incannex Healthcare (IXHL) Interest Expenses (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Interest Expenses for 4 years, with the latest figure at $123000.0 in Q1 2026.
- Quarterly Interest Expenses fell 61.32% year-over-year to $123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123000.0 (down 61.32% YoY) and the FY2025 annual result came in at $303000.0, down 99.82% from the prior year.
- Interest Expenses slipped to $123000.0 in Q1 2026 per IXHL's latest filing, from $176000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $171.9 million in Q2 2024 and troughed at $123000.0 in Q1 2026.
- A 4-year average of $15.9 million and a median of $363000.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2026: Interest Expenses soared 115254.36% in 2024, then tumbled 61.32% in 2026.
- Over 4 years, Interest Expenses stood at $609000.0 in 2023, then plunged by 40.39% to $363000.0 in 2024, then tumbled by 51.52% to $176000.0 in 2025, then slumped by 30.11% to $123000.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $123000.0, $176000.0, and $227000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 41.61 Mn | 41.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123,000.00 |
| Mar 31, 2026 | 123,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 227,000.00 |
| Sep 30, 2025 | 227,000.00 |
| Mar 31, 2025 | 318,000.00 |
| Mar 31, 2025 | 318,000.00 |
| Dec 31, 2024 | 363,000.00 |
| Dec 31, 2024 | 363,000.00 |
| Sep 30, 2024 | 458,000.00 |
| Sep 30, 2024 | 458,000.00 |
| Jun 30, 2024 | 171.88 Mn |
| Jun 30, 2024 | 171.88 Mn |
| Mar 31, 2024 | 534,000.00 |
| Mar 31, 2024 | 534,000.00 |
| Dec 31, 2023 | 609,000.00 |
| Dec 31, 2023 | 609,000.00 |
| Sep 30, 2023 | 442,000.00 |
| Sep 30, 2023 | 442,000.00 |